APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pasireotide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pasireotide Market Analysis and Forecast 2026-2032

22 December 2025195 pages

Choose your research edition.

Industry ResearchPasireotide Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Pasireotide Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Pasireotide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pasireotide Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pasireotide Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pasireotide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pasireotide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pasireotide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pasireotide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pasireotide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pasireotide include Recordati Rare Diseases. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pasireotide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pasireotide, also provides the sales of main regions and countries. Of the upcoming market potential for Pasireotide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pasireotide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pasireotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pasireotide sales, projected growth trends, production technology, application and end-user industry.

Pasireotide Segment by Company

Recordati Rare Diseases

Pasireotide Segment by Type

0.9mg/ml

0.6mg/ml

0.3mg/ml

Pasireotide Segment by Application

Hospital

Pharmacy

Pasireotide Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pasireotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pasireotide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pasireotide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pasireotide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pasireotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pasireotide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pasireotide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.9mg/ml Major Manufacturers Table 3. 0.6mg/ml Major Manufacturers Table 4. 0.3mg/ml Major Manufacturers Table 5. Global Pasireotide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Pasireotide Industry Trends Table 9. Pasireotide Industry Drivers Table 10. Pasireotide Industry Opportunities and Challenges Table 11. Pasireotide Industry Restraints Table 12. Global Pasireotide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Pasireotide Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Pasireotide Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Pasireotide Revenue Market Share by Region (2021-2026) Table 16. Global Pasireotide Revenue Market Share by Region (2027-2032) Table 17. Global Pasireotide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (units) Table 18. Global Pasireotide Sales by Region (2021-2026) & (units) Table 19. Global Pasireotide Sales by Region (2027-2032) & (units) Table 20. Global Pasireotide Sales Market Share by Region (2021-2026) Table 21. Global Pasireotide Sales Market Share by Region (2027-2032) Table 22. Global Pasireotide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Pasireotide Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Pasireotide Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Pasireotide Sales Market Share by Manufacturers (2021-2026) Table 26. Global Pasireotide Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Pasireotide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Pasireotide Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Pasireotide Manufacturers, Product Type & Application Table 30. Global Pasireotide Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Pasireotide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Pasireotide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pasireotide Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Pasireotide Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Pasireotide Revenue Market Share by Type (2021-2026) Table 37. Global Pasireotide Revenue Market Share by Type (2027-2032) Table 38. Global Pasireotide Sales by Type 2021 VS 2025 VS 2032 (units) Table 39. Global Pasireotide Sales by Type (2021-2026) & (units) Table 40. Global Pasireotide Sales by Type (2027-2032) & (units) Table 41. Global Pasireotide Sales Market Share by Type (2021-2026) Table 42. Global Pasireotide Sales Market Share by Type (2027-2032) Table 43. Global Pasireotide Price by Type (2021-2026) & (US$/unit) Table 44. Global Pasireotide Price by Type (2027-2032) & (US$/unit) Table 45. Global Pasireotide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Pasireotide Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Pasireotide Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Pasireotide Revenue Market Share by Application (2021-2026) Table 49. Global Pasireotide Revenue Market Share by Application (2027-2032) Table 50. Global Pasireotide Sales by Application 2021 VS 2025 VS 2032 (units) Table 51. Global Pasireotide Sales by Application (2021-2026) & (units) Table 52. Global Pasireotide Sales by Application (2027-2032) & (units) Table 53. Global Pasireotide Sales Market Share by Application (2021-2026) Table 54. Global Pasireotide Sales Market Share by Application (2027-2032) Table 55. Global Pasireotide Price by Application (2021-2026) & (US$/unit) Table 56. Global Pasireotide Price by Application (2027-2032) & (US$/unit) Table 57. Recordati Rare Diseases Company Information Table 58. Recordati Rare Diseases Business Overview Table 59. Recordati Rare Diseases Pasireotide Sales (units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Recordati Rare Diseases Pasireotide Product Portfolio Table 61. Recordati Rare Diseases Recent Development Table 62. North America Pasireotide Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Pasireotide Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Pasireotide Sales by Type (2021-2026) & (units) Table 65. North America Pasireotide Sales by Type (2027-2032) & (units) Table 66. North America Pasireotide Sales Price by Type (2021-2026) & (US$/unit) Table 67. North America Pasireotide Sales Price by Type (2027-2032) & (US$/unit) Table 68. North America Pasireotide Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Pasireotide Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Pasireotide Sales by Application (2021-2026) & (units) Table 71. North America Pasireotide Sales by Application (2027-2032) & (units) Table 72. North America Pasireotide Sales Price by Application (2021-2026) & (US$/unit) Table 73. North America Pasireotide Sales Price by Application (2027-2032) & (US$/unit) Table 74. North America Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Pasireotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 76. North America Pasireotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 77. North America Pasireotide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 78. North America Pasireotide Sales by Country (2021-2026) & (units) Table 79. North America Pasireotide Sales by Country (2027-2032) & (units) Table 80. North America Pasireotide Sales Price by Country (2021-2026) & (US$/unit) Table 81. North America Pasireotide Sales Price by Country (2027-2032) & (US$/unit) Table 82. United States Pasireotide Revenue (2021-2032) & (US$ Million) Table 83. Canada Pasireotide Revenue (2021-2032) & (US$ Million) Table 84. Mexico Pasireotide Revenue (2021-2032) & (US$ Million) Table 85. Europe Pasireotide Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe Pasireotide Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe Pasireotide Sales by Type (2021-2026) & (units) Table 88. Europe Pasireotide Sales by Type (2027-2032) & (units) Table 89. Europe Pasireotide Sales Price by Type (2021-2026) & (US$/unit) Table 90. Europe Pasireotide Sales Price by Type (2027-2032) & (US$/unit) Table 91. Europe Pasireotide Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Pasireotide Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Pasireotide Sales by Application (2021-2026) & (units) Table 94. Europe Pasireotide Sales by Application (2027-2032) & (units) Table 95. Europe Pasireotide Sales Price by Application (2021-2026) & (US$/unit) Table 96. Europe Pasireotide Sales Price by Application (2027-2032) & (US$/unit) Table 97. Europe Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Pasireotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. Europe Pasireotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. Europe Pasireotide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 101. Europe Pasireotide Sales by Country (2021-2026) & (units) Table 102. Europe Pasireotide Sales by Country (2027-2032) & (units) Table 103. Europe Pasireotide Sales Price by Country (2021-2026) & (US$/unit) Table 104. Europe Pasireotide Sales Price by Country (2027-2032) & (US$/unit) Table 105. Germany Pasireotide Revenue (2021-2032) & (US$ Million) Table 106. France Pasireotide Revenue (2021-2032) & (US$ Million) Table 107. U.K. Pasireotide Revenue (2021-2032) & (US$ Million) Table 108. Italy Pasireotide Revenue (2021-2032) & (US$ Million) Table 109. Russia Pasireotide Revenue (2021-2032) & (US$ Million) Table 110. Spain Pasireotide Revenue (2021-2032) & (US$ Million) Table 111. Netherlands Pasireotide Revenue (2021-2032) & (US$ Million) Table 112. Switzerland Pasireotide Revenue (2021-2032) & (US$ Million) Table 113. Sweden Pasireotide Revenue (2021-2032) & (US$ Million) Table 114. Poland Pasireotide Revenue (2021-2032) & (US$ Million) Table 115. China Pasireotide Revenue by Type (2021-2026) & (US$ Million) Table 116. China Pasireotide Revenue by Type (2027-2032) & (US$ Million) Table 117. China Pasireotide Sales by Type (2021-2026) & (units) Table 118. China Pasireotide Sales by Type (2027-2032) & (units) Table 119. China Pasireotide Sales Price by Type (2021-2026) & (US$/unit) Table 120. China Pasireotide Sales Price by Type (2027-2032) & (US$/unit) Table 121. China Pasireotide Revenue by Application (2021-2026) & (US$ Million) Table 122. China Pasireotide Revenue by Application (2027-2032) & (US$ Million) Table 123. China Pasireotide Sales by Application (2021-2026) & (units) Table 124. China Pasireotide Sales by Application (2027-2032) & (units) Table 125. China Pasireotide Sales Price by Application (2021-2026) & (US$/unit) Table 126. China Pasireotide Sales Price by Application (2027-2032) & (US$/unit) Table 127. Asia Pasireotide Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Pasireotide Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Pasireotide Sales by Type (2021-2026) & (units) Table 130. Asia Pasireotide Sales by Type (2027-2032) & (units) Table 131. Asia Pasireotide Sales Price by Type (2021-2026) & (US$/unit) Table 132. Asia Pasireotide Sales Price by Type (2027-2032) & (US$/unit) Table 133. Asia Pasireotide Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Pasireotide Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Pasireotide Sales by Application (2021-2026) & (units) Table 136. Asia Pasireotide Sales by Application (2027-2032) & (units) Table 137. Asia Pasireotide Sales Price by Application (2021-2026) & (US$/unit) Table 138. Asia Pasireotide Sales Price by Application (2027-2032) & (US$/unit) Table 139. Asia Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Pasireotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia Pasireotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia Pasireotide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 143. Asia Pasireotide Sales by Country (2021-2026) & (units) Table 144. Asia Pasireotide Sales by Country (2027-2032) & (units) Table 145. Asia Pasireotide Sales Price by Country (2021-2026) & (US$/unit) Table 146. Asia Pasireotide Sales Price by Country (2027-2032) & (US$/unit) Table 147. Japan Pasireotide Revenue (2021-2032) & (US$ Million) Table 148. South Korea Pasireotide Revenue (2021-2032) & (US$ Million) Table 149. India Pasireotide Revenue (2021-2032) & (US$ Million) Table 150. Australia Pasireotide Revenue (2021-2032) & (US$ Million) Table 151. Taiwan Pasireotide Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia Pasireotide Revenue (2021-2032) & (US$ Million) Table 153. SAMEA Pasireotide Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Pasireotide Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Pasireotide Sales by Type (2021-2026) & (units) Table 156. SAMEA Pasireotide Sales by Type (2027-2032) & (units) Table 157. SAMEA Pasireotide Sales Price by Type (2021-2026) & (US$/unit) Table 158. SAMEA Pasireotide Sales Price by Type (2027-2032) & (US$/unit) Table 159. SAMEA Pasireotide Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA Pasireotide Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA Pasireotide Sales by Application (2021-2026) & (units) Table 162. SAMEA Pasireotide Sales by Application (2027-2032) & (units) Table 163. SAMEA Pasireotide Sales Price by Application (2021-2026) & (US$/unit) Table 164. SAMEA Pasireotide Sales Price by Application (2027-2032) & (US$/unit) Table 165. SAMEA Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Pasireotide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA Pasireotide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA Pasireotide Sales by Country (2021 VS 2025 VS 2032) & (units) Table 169. SAMEA Pasireotide Sales by Country (2021-2026) & (units) Table 170. SAMEA Pasireotide Sales by Country (2027-2032) & (units) Table 171. SAMEA Pasireotide Sales Price by Country (2021-2026) & (US$/unit) Table 172. SAMEA Pasireotide Sales Price by Country (2027-2032) & (US$/unit) Table 173. Brazil Pasireotide Revenue (2021-2032) & (US$ Million) Table 174. Argentina Pasireotide Revenue (2021-2032) & (US$ Million) Table 175. Chile Pasireotide Revenue (2021-2032) & (US$ Million) Table 176. Colombia Pasireotide Revenue (2021-2032) & (US$ Million) Table 177. Peru Pasireotide Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia Pasireotide Revenue (2021-2032) & (US$ Million) Table 179. Israel Pasireotide Revenue (2021-2032) & (US$ Million) Table 180. UAE Pasireotide Revenue (2021-2032) & (US$ Million) Table 181. Turkey Pasireotide Revenue (2021-2032) & (US$ Million) Table 182. Iran Pasireotide Revenue (2021-2032) & (US$ Million) Table 183. Egypt Pasireotide Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Pasireotide Distributors List Table 187. Pasireotide Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Pasireotide Image Figure 2. Global Pasireotide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pasireotide Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.9mg/ml Image Figure 5. 0.6mg/ml Image Figure 6. 0.3mg/ml Image Figure 7. Global Pasireotide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Pasireotide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Global Pasireotide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Pasireotide Revenue (2021-2032) & (US$ Million) Figure 13. Global Pasireotide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Pasireotide Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Pasireotide Revenue Market Share by Region (2021-2032) Figure 16. Global Pasireotide Sales (2021-2032) & (units) Figure 17. Global Pasireotide Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 18. Global Pasireotide Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Pasireotide Sales YoY (2021-2032) & (units) Figure 20. Europe Pasireotide Sales YoY (2021-2032) & (units) Figure 21. China Pasireotide Sales YoY (2021-2032) & (units) Figure 22. Asia (Excluding China) Pasireotide Sales YoY (2021-2032) & (units) Figure 23. South America, Middle East and Africa Pasireotide Sales YoY (2021-2032) & (units) Figure 24. Global Pasireotide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Pasireotide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Pasireotide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Pasireotide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Pasireotide Revenue Market Share by Type (2021-2032) Figure 30. Global Pasireotide Sales by Type (2021 VS 2025 VS 2032) & (units) Figure 31. Global Pasireotide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Pasireotide Sales Market Share by Type (2021-2032) Figure 33. Global Pasireotide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Pasireotide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Pasireotide Revenue Market Share by Application (2021-2032) Figure 36. Global Pasireotide Sales by Application (2021 VS 2025 VS 2032) & (units) Figure 37. Global Pasireotide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Pasireotide Sales Market Share by Application (2021-2032) Figure 39. North America Pasireotide Revenue Share by Type (2021-2032) Figure 40. North America Pasireotide Sales Share by Type (2021-2032) Figure 41. North America Pasireotide Revenue Share by Application (2021-2032) Figure 42. North America Pasireotide Sales Share by Application (2021-2032) Figure 43. North America Pasireotide Revenue Share by Country (2021-2032) Figure 44. North America Pasireotide Sales Share by Country (2021-2032) Figure 45. Europe Pasireotide Revenue Share by Type (2021-2032) Figure 46. Europe Pasireotide Sales Share by Type (2021-2032) Figure 47. Europe Pasireotide Revenue Share by Application (2021-2032) Figure 48. Europe Pasireotide Sales Share by Application (2021-2032) Figure 49. Europe Pasireotide Revenue Share by Country (2021-2032) Figure 50. Europe Pasireotide Sales Share by Country (2021-2032) Figure 51. China Pasireotide Revenue Share by Type (2021-2032) Figure 52. China Pasireotide Sales Share by Type (2021-2032) Figure 53. China Pasireotide Revenue Share by Application (2021-2032) Figure 54. China Pasireotide Sales Share by Application (2021-2032) Figure 55. Asia Pasireotide Revenue Share by Type (2021-2032) Figure 56. Asia Pasireotide Sales Share by Type (2021-2032) Figure 57. Asia Pasireotide Revenue Share by Application (2021-2032) Figure 58. Asia Pasireotide Sales Share by Application (2021-2032) Figure 59. Asia Pasireotide Revenue Share by Country (2021-2032) Figure 60. Asia Pasireotide Sales Share by Country (2021-2032) Figure 61. SAMEA Pasireotide Revenue Share by Type (2021-2032) Figure 62. SAMEA Pasireotide Sales Share by Type (2021-2032) Figure 63. SAMEA Pasireotide Revenue Share by Application (2021-2032) Figure 64. SAMEA Pasireotide Sales Share by Application (2021-2032) Figure 65. SAMEA Pasireotide Revenue Share by Country (2021-2032) Figure 66. SAMEA Pasireotide Sales Share by Country (2021-2032) Figure 67. Pasireotide Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pasireotide Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 0.9mg/ml
  • 0.6mg/ml
  • 0.3mg/ml
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Recordati Rare Diseases

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pasireotide Market by Type
  3. 1.2.1 Global Pasireotide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.9mg/ml
  5. 1.2.3 0.6mg/ml
  6. 1.2.4 0.3mg/ml
  7. 1.3 Pasireotide Market by Application
  8. 1.3.1 Global Pasireotide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Pasireotide Market Dynamics
  1. 2.1 Pasireotide Industry Trends
  2. 2.2 Pasireotide Industry Drivers
  3. 2.3 Pasireotide Industry Opportunities and Challenges
  4. 2.4 Pasireotide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pasireotide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pasireotide Revenue by Region
  3. 3.2.1 Global Pasireotide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pasireotide Revenue by Region (2021-2026)
  5. 3.2.3 Global Pasireotide Revenue by Region (2027-2032)
  6. 3.2.4 Global Pasireotide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pasireotide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pasireotide Sales by Region
  9. 3.4.1 Global Pasireotide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pasireotide Sales by Region (2021-2026)
  11. 3.4.3 Global Pasireotide Sales by Region (2027-2032)
  12. 3.4.4 Global Pasireotide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pasireotide Revenue by Manufacturers
  2. 4.1.1 Global Pasireotide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pasireotide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pasireotide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pasireotide Sales by Manufacturers
  6. 4.2.1 Global Pasireotide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pasireotide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pasireotide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pasireotide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pasireotide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pasireotide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pasireotide Manufacturers, Product Type & Application
  13. 4.7 Global Pasireotide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pasireotide Market CR5 and HHI
  16. 4.8.2 2025 Pasireotide Tier 1, Tier 2, and Tier 3
5 Pasireotide Market by Type
  1. 5.1 Global Pasireotide Revenue by Type
  2. 5.1.1 Global Pasireotide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pasireotide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pasireotide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pasireotide Sales by Type
  6. 5.2.1 Global Pasireotide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pasireotide Sales by Type (2021-2032) & (units)
  8. 5.2.3 Global Pasireotide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pasireotide Price by Type
6 Pasireotide Market by Application
  1. 6.1 Global Pasireotide Revenue by Application
  2. 6.1.1 Global Pasireotide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pasireotide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pasireotide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pasireotide Sales by Application
  6. 6.2.1 Global Pasireotide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pasireotide Sales by Application (2021-2032) & (units)
  8. 6.2.3 Global Pasireotide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pasireotide Price by Application
7 Company Profiles
  1. 7.1 Recordati Rare Diseases
  2. 7.1.1 Recordati Rare Diseases Company Information
  3. 7.1.2 Recordati Rare Diseases Business Overview
  4. 7.1.3 Recordati Rare Diseases Pasireotide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Recordati Rare Diseases Pasireotide Product Portfolio
  6. 7.1.5 Recordati Rare Diseases Recent Developments
8 North America
  1. 8.1 North America Pasireotide Market Size by Type
  2. 8.1.1 North America Pasireotide Revenue by Type (2021-2032)
  3. 8.1.2 North America Pasireotide Sales by Type (2021-2032)
  4. 8.1.3 North America Pasireotide Price by Type (2021-2032)
  5. 8.2 North America Pasireotide Market Size by Application
  6. 8.2.1 North America Pasireotide Revenue by Application (2021-2032)
  7. 8.2.2 North America Pasireotide Sales by Application (2021-2032)
  8. 8.2.3 North America Pasireotide Price by Application (2021-2032)
  9. 8.3 North America Pasireotide Market Size by Country
  10. 8.3.1 North America Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pasireotide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pasireotide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pasireotide Market Size by Type
  2. 9.1.1 Europe Pasireotide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pasireotide Sales by Type (2021-2032)
  4. 9.1.3 Europe Pasireotide Price by Type (2021-2032)
  5. 9.2 Europe Pasireotide Market Size by Application
  6. 9.2.1 Europe Pasireotide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pasireotide Sales by Application (2021-2032)
  8. 9.2.3 Europe Pasireotide Price by Application (2021-2032)
  9. 9.3 Europe Pasireotide Market Size by Country
  10. 9.3.1 Europe Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pasireotide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pasireotide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pasireotide Market Size by Type
  2. 10.1.1 China Pasireotide Revenue by Type (2021-2032)
  3. 10.1.2 China Pasireotide Sales by Type (2021-2032)
  4. 10.1.3 China Pasireotide Price by Type (2021-2032)
  5. 10.2 China Pasireotide Market Size by Application
  6. 10.2.1 China Pasireotide Revenue by Application (2021-2032)
  7. 10.2.2 China Pasireotide Sales by Application (2021-2032)
  8. 10.2.3 China Pasireotide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pasireotide Market Size by Type
  2. 11.1.1 Asia Pasireotide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pasireotide Sales by Type (2021-2032)
  4. 11.1.3 Asia Pasireotide Price by Type (2021-2032)
  5. 11.2 Asia Pasireotide Market Size by Application
  6. 11.2.1 Asia Pasireotide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pasireotide Sales by Application (2021-2032)
  8. 11.2.3 Asia Pasireotide Price by Application (2021-2032)
  9. 11.3 Asia Pasireotide Market Size by Country
  10. 11.3.1 Asia Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pasireotide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pasireotide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pasireotide Market Size by Type
  2. 12.1.1 SAMEA Pasireotide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pasireotide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pasireotide Price by Type (2021-2032)
  5. 12.2 SAMEA Pasireotide Market Size by Application
  6. 12.2.1 SAMEA Pasireotide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pasireotide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pasireotide Price by Application (2021-2032)
  9. 12.3 SAMEA Pasireotide Market Size by Country
  10. 12.3.1 SAMEA Pasireotide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pasireotide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pasireotide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pasireotide Value Chain Analysis
  2. 13.1.1 Pasireotide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pasireotide Production Mode & Process
  6. 13.2 Pasireotide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pasireotide Distributors
  9. 13.2.3 Pasireotide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst